SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ALEMBIC PHARMACEUTICALS

BSE: 533573 29 Sep 2025
Healthcare
₹ 972.5
ALEMBIC PHARMACEUTICALS LIMITED specializes in Pharmaceuticals within the Healthcare sector.

ALEMBIC PHARMACEUTICALS - Share Price & Details

Market Cap
₹17,885
High /Low
1,304 / 725.0
Stock P/E
30.2
Book Value
₹264.0
Dividend Yield
1.21
ROCE
13.0
ROE
₹11.4
Face Value
2.0
PEG Ratio
9.48
EVEBITDA
₹17.3
Debt
1,258
CMP / FCF
177.0
Debt to equity
₹0.24
NP Ann
582
High price all time
1,304
Piotroski score
₹5.0
Graham Number
427.0
No. Eq. Shares
19.7
Net CF
₹-36.7
Net profit
601
Price to book value
3.45
Interest Coverage
₹9.16
Low price all time
31.0
Industry PE
33.0
Reserves
₹5,152
Free Cash Flow
₹-466

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
06 Aug 2025 ICICI Securities Hold ₹946.9 ₹900 -5% moneycontrol View
05 Aug 2025 Motilal Oswal Hold ₹946.9 ₹990 5.7% moneycontrol View
06 May 2025 Motilal Oswal Hold ₹887.6 ₹930 3.6% moneycontrol View
06 Feb 2025 KRChoksey Hold ₹894.2 ₹909 1.5% moneycontrol View
04 Feb 2025 ICICI Securities Hold ₹880.35 ₹925 5.7% moneycontrol View
03 Feb 2025 Motilal Oswal Hold ₹908.5 ₹970 9.1% moneycontrol View
08 Nov 2024 KRChoksey Hold ₹1,039 ₹1,087 -1.1% moneycontrol View
07 Nov 2024 Motilal Oswal Hold ₹1,081.45 ₹1,110 0.9% moneycontrol View
14 May 2024 KRChoksey Hold ₹963.95 ₹986 -10.3% moneycontrol View
14 May 2024 Motilal Oswal Hold ₹963.95 ₹960 -12.6% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
ALEMBIC PHARMACEUTICALS LTD.15019.61035.214941.75.2717,88530.2
530019602.058.0595.00.261661334.2
Concord Biotech Limited2176.65425.652039.884.071637746.0

Peer Comparison Chart


About ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS LIMITED, with Security Code 533573, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Alembic Pharmaceuticals receives EIR for API - I and API - II facility located at Panelav

(16 Sep 2025)
Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) for the inspection conducted by the US Food and Drug...
Read more →

Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its API - I & API - II Facility located at Panelav.

(16 Sep 2025)
Mumbai: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) for the inspection conducted by the US Food...
Read more →

Alembic Pharma Gets EIR for API-I & II Facility at Panelav

(15 Sep 2025)
Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) for the inspection conducted by the US Food and Drug...
Read more →

Alembic Pharma Receives USFDA Compliance Report for Panelav Facilities

(15 Sep 2025)
Alembic Pharmaceuticals Ltd. said on Saturday it has received an Establishment Inspection Report (EIR) from the US Food and Drug...
Read more →

Briefs: Alembic Pharmaceuticals and Tyche Industries

(14 Sep 2025)
Alembic receives EIR from USFDA for facility at Panelav. Alembic Pharmaceuticals Limited has received Establishment Inspection Report (EIR)...
Read more →

USFDA clears Alembic Pharma’s Panelav manufacturing units after inspection

(14 Sep 2025)
Alembic Pharmaceuticals Limited on Saturday said it has received an Establishment Inspection Report (EIR) from the US Food and Drug...
Read more →